Lucid Diagnostics (LUCD) Share-based Compensation (2020 - 2026)
Lucid Diagnostics' (LUCD) quarterly Share-based Compensation came in at $30000.0 in Q1 2026, down 97.09% YoY from $1.0 million in Q1 2025, and down 97.42% on a QoQ basis from $1.2 million in Q4 2025.
Lucid Diagnostics (LUCD) Share-based Compensation (2020 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 7 years of Share-based Compensation data on file, last reported at $30000.0 in Q1 2026.
- Quarterly Share-based Compensation fell 97.09% year-over-year to $30000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30000.0 (down 99.4% YoY) and the FY2025 annual result came in at $4.5 million, down 0.95% from the prior year.
- Share-based Compensation eased to $30000.0 in Q1 2026, from $1.2 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $3.8 million in Q2 2022 to a low of $30000.0 in Q1 2026.
- A 5-year average of $1.8 million and a median of $1.2 million in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation jumped 376.4% — and 2026, when it slumped 97.09%.
- Tracing LUCD's Share-based Compensation over 5 years: stood at $3.5 million in 2022, then slumped by 72.39% to $963000.0 in 2023, then jumped by 55.76% to $1.5 million in 2024, then decreased by 22.33% to $1.2 million in 2025, then sank by 97.42% to $30000.0 in 2026.
- The last three Share-based Compensation figures came in at $30000.0 (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Lucid Diagnostics | 175.80 Mn | 142.40 Mn | 55,000.00 | 1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.69 Mn |
| Jun 30, 2026 | 1.69 Mn |
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | 1.17 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 743,000.00 |
| Mar 31, 2024 | 743,000.00 |